SA’s medicines regulator has suspended two members of its inspectorate and is facing a probe from the Special Investigating Unit (SIU) for alleged fraud relating to an undisclosed "external stakeholder".

The probe raises questions about the processes for seeking regulatory approval for medicines and manufacturing sites and whether they have been tampered with, as well as the integrity of the products on the market. But the SA Health Products Regulatory Agency (Sahpra) assured consumers on Monday that the investigation will not affect the health and safety of the public "in any way"...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.